In the UK, medications are classified under different schedules based on their potential for harm, misuse, and therapeutic value. Schedule 2 medicines, also known as controlled drugs, are substances that have potential for abuse or misuse but are recognised to have legitimate medical uses. These medications are subject to strict regulations regarding their production, prescription, […]

The Curaleaf Access Scheme provides reduced clinical review costs for patients who contribute to Curaleaf’s evidence platform, the UK Medical Cannabis Registry. This allows patients to access the same high quality care, whilst also contributing their anonymous data to growing the evidence base of medical cannabis in the UK.

Also known as PROMS, are questionnaires that have been shown in research studies to be an effective way of tracking changes in the specific indications they were made to monitor.

A patient registry is a systematic collection of standardised information about individuals diagnosed with a particular medical condition or disease. These registries are designed to gather comprehensive data on patients’ demographics, medical history, treatments received, outcomes, and other relevant factors. Curaleaf Clinic has set up the UK Medical Cannabis Registry, the largest real-world dataset on […]

Medical cannabis refers to specific cannabis-based products that are only available on prescription. The products must be manufactured in accordance with regulations set out by regulators to ensure their consistency and they meet pharmaceutical standards. Medical cannabis is dispensed in various forms, including oil administered under the tongue; dried cannabis inhaled with a vaporiser; ointments […]

A group of healthcare professionals who are specialist in a variety of different illnesses or are from different professional backgrounds, who meet to discuss treatment of patients to ensure the best possible outcomes.

The formulary is a list of prescription medicines that can be dispensed on a private prescription from Curaleaf.

The endocannabinoid system (also called ECS) is a network of receptors, molecules (endocannabinoids), and enzymes found inside the human body. This system is found throughout the human body, including the brain, spinal cord, gut, and immune system. The role it plays depends on many factors, but it is ultimately a regulatory system. Research suggests that […]

The Care Quality Commission (commonly known as the CQC) are the independent regulator of health and social care in England. The CQC ensures health and social care services provide people with safe, effective, compassionate, high-quality care and encourages care services to maintain high standards. Curaleaf was the first medical cannabis clinic registered by the CQC […]

Cannabidiol (commonly known as CBD) is one of the two most prevalent active ingredients found in the cannabis plant. Curaleaf prescribes CBD of a pharmaceutical grade standard, which significantly differs in quality from CBD available over the counter. Patients may be eligible for medical CBD if they have been prescribed two or more licensed medications […]

Adverse Events are any negative effects as a result of the medicine. If you experience any side effects from medical cannabis, report these to us at [email protected]. We report all adverse events through the Yellow Card Scheme.